Skip to main content
NCBI home page
British Medical Journal logoLink to British Medical Journal
. 1974 Feb 23;1(5903):297. doi: 10.1136/bmj.1.5903.297

Editorial: Mental side effects of pentazocine.

PMCID: PMC1633376  PMID: 4819146

Full text

PDF

Page 297

297

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berkowitz B. A., Asling J. H., Shnider S. M., Way E. L. Relationship of pentazocine plasma levels to pharmacological activity in man. Clin Pharmacol Ther. 1969 May-Jun;10(3):320–328. doi: 10.1002/cpt1969103320. [DOI] [PubMed] [Google Scholar]
  2. Berkowitz B., Way E. L. Metabolism and excretion of pentazocine in man. Clin Pharmacol Ther. 1969 Sep-Oct;10(5):681–689. doi: 10.1002/cpt1969105681. [DOI] [PubMed] [Google Scholar]
  3. Burt R. A., Beckett A. H. The absorption and excretion of pentazocine after administration by different routes. Br J Anaesth. 1971 May;43(5):427–435. doi: 10.1093/bja/43.5.427. [DOI] [PubMed] [Google Scholar]
  4. DeNosaquo N. The hallucinatory effect of pentazocine (Talwin). JAMA. 1969 Oct 20;210(3):502–502. doi: 10.1001/jama.210.3.502. [DOI] [PubMed] [Google Scholar]
  5. Forrest W. H., Jr, Beer E. G., Bellville J. W., Ciliberti B. J., Miller E. V., Paddock R. Analgesic and other effects of the d- and l-isomers of penzocine. Clin Pharmacol Ther. 1969 Jul-Aug;10(4):468–476. doi: 10.1002/cpt1969104468. [DOI] [PubMed] [Google Scholar]
  6. Hart R. H. Pentazocine addiction. Lancet. 1969 Sep 27;2(7622):690–690. doi: 10.1016/s0140-6736(69)90393-6. [DOI] [PubMed] [Google Scholar]
  7. Jewitt D. E., Maurer B. J., Hubner P. J. Increased pulmonary arterial pressures after pentazocine in myocardial infarction. Br Med J. 1970 Mar 28;1(5699):795–796. doi: 10.1136/bmj.1.5699.795. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. KEATS A. S., TELFORD J. STUDIES OF ANALGESIC DRUGS. VIII. A NARCOTIC ANTAGONIST ANALGESIC WITHOUT PSYCHOTOMIMETIC EFFECTS. J Pharmacol Exp Ther. 1964 Feb;143:157–164. [PubMed] [Google Scholar]
  9. Kantor T. G., Sunshine A., Laska E., Meisner M., Hopper M. Oral analgesic studies: pentazocine hydrochloride, codeine, aspirin, and placebo and their influence on response to placebo. Clin Pharmacol Ther. 1966 Jul-Aug;7(4):447–454. doi: 10.1002/cpt196674447. [DOI] [PubMed] [Google Scholar]
  10. Paddock R., Beer E. G., Bellville J. W., Ciliberti B. J., Forrest W. H., Jr, Miller E. V. Analgesic and side effects of pentazocine and morphine in a large population of postoperative patients. Clin Pharmacol Ther. 1969 May-Jun;10(3):355–365. doi: 10.1002/cpt1969103355. [DOI] [PubMed] [Google Scholar]
  11. Sandoval R. G., Wang R. I. Tolerance and dependence on pentazocine. N Engl J Med. 1969 Jun 19;280(25):1391–1392. doi: 10.1056/NEJM196906192802506. [DOI] [PubMed] [Google Scholar]
  12. Schoolar J. C., Idänpän-Heikkilä P., Keats A. S. Pentazocine addiction? Lancet. 1969 Jun 21;1(7608):1263–1263. doi: 10.1016/s0140-6736(69)92140-0. [DOI] [PubMed] [Google Scholar]
  13. Scott M. E., Orr R. Effects of diamorphine, methadone, morphine, and pentazocine in patients with suspected acute myocardial infarction. Lancet. 1969 May 31;1(7605):1065–1067. doi: 10.1016/s0140-6736(69)91704-8. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES